Stay updated with breaking news from General Biomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Farmington-based bioscience startup is hoping its technology can help with the early detection of newborn illnesses, saving lives and possibly billions of dollars in spending on healthcare services.
With an eye toward possible expansion of The Jackson Laboratory for Genomic Medicine in Farmington, new spinoffs and possibly new hires down the road, longtime researcher and academic Dr. Lon Cardon will take the helm as president and CEO of the seven-year-old growing facility on Nov. 29. The 56-year-old Cardon — who is currently the chief science strategic officer of California-based BioMarin Pharmaceutical Inc. — will replace current president and CEO Dr. Edison Liu.